` Comparison: MBX, NOVO B - Alpha Spread

M
MBX
vs
NOVO B

Over the past 12 months, MBX has significantly outperformed NOVO B, delivering a return of -9% compared to the NOVO B's 49% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
MBX
NOVO B
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

M
MBX Intrinsic Value
7.84 USD
Overvaluation 46%
Intrinsic Value
Price
NOVO B Intrinsic Value
644.98 DKK
Undervaluation 30%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
M
MBX Biosciences Inc
NASDAQ:MBX
14.57 USD
Novo Nordisk A/S
CSE:NOVO B
452.1 DKK
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
MBX, NOVO B

MBX
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
M
MBX Biosciences Inc
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
MBX, NOVO B

MBX
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
M
MBX Biosciences Inc
NASDAQ:MBX
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

MBX
0%
NOVO B
84.3%
LTM 3Y Avg 5Y Avg 10Y Avg
M
MBX Biosciences Inc
Novo Nordisk A/S

Operating Margin

MBX
0%
NOVO B
44.6%
LTM 3Y Avg 5Y Avg 10Y Avg
M
MBX Biosciences Inc
Novo Nordisk A/S

Net Margin

MBX
0%
NOVO B
34.5%
LTM 3Y Avg 5Y Avg 10Y Avg
M
MBX Biosciences Inc
Novo Nordisk A/S

FCF Margin

MBX
0%
NOVO B
24.5%
LTM 3Y Avg 5Y Avg 10Y Avg
M
MBX Biosciences Inc
Novo Nordisk A/S

ROE

MBX
-48.2%
NOVO B
88.1%
LTM 3Y Avg 5Y Avg 10Y Avg
M
MBX Biosciences Inc
Novo Nordisk A/S

ROA

MBX
-45.7%
NOVO B
26.6%
LTM 3Y Avg 5Y Avg 10Y Avg
M
MBX Biosciences Inc
Novo Nordisk A/S

ROIC

MBX
-6 023.6%
NOVO B
30.4%
LTM 3Y Avg 5Y Avg 10Y Avg
M
MBX Biosciences Inc
Novo Nordisk A/S

ROCE

MBX
-53.4%
NOVO B
70%
LTM 3Y Avg 5Y Avg 10Y Avg
M
MBX Biosciences Inc
Novo Nordisk A/S

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
MBX, NOVO B

Loading

Performance Gap
MBX, NOVO B

Loading
MBX
NOVO B
Difference
www.alphaspread.com

Performance By Year
MBX, NOVO B

Loading
MBX
NOVO B
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare MBX to other stocks
Unlock Full Access to Alpha Spread
Create Free Account